Literature DB >> 9107364

Seroprevalence and coprevalence of HIV and HBsAg in Nigerian children with/without protein energy malnutrition.

F O Akenami1, M Koskiniemi, E E Ekanem, D M Bolarin, A Vaheri.   

Abstract

In order to assess the seroprevalence and coprevalence of hepatitis-B surface antigen (HBsAg), human immunodeficiency virus-1 and -2 (HIV-1 and -2) antibodies in Nigerian children with/without protein energy malnutrition (PEM), we studied plasma specimens of 206 children with PEM and 200 apparently healthy reference children aged between 1 and 3 years by enzyme-linked immunosorbent assays (ELISA). HIV-seropositive cases were confirmed by immunoblotting (IB). Of the children studied, eight (4%) of the healthy and four (1.9%) of the malnourished (P = 0.22, Fisher's exact test) were positive for HIV-1 antibodies, 40 (20%) of the healthy and 54 (26%) of the malnourished (P = 0.14) were positive for HBsAg, and five (2.5%) of the healthy and four (1.9%) of the malnourished (P = 0.70) were positive for both HIV-1/HBsAg. No case of HIV-2 antibodies was found. While the seroprevalence of HBsAg was higher in the malnourished subjects, the reverse was the case with HIV antibodies. However, all the four HIV-1-positive malnourished children and five of eight of the HIV-1-positive reference children were simultaneously positive for HBsAg. This is the first epidemiological report on the seroprevalence and coprevalence of HIV and HBsAg in apparently healthy and malnourished Nigerian children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107364     DOI: 10.1016/s0001-706x(96)00629-8

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

Review 1.  Macronutrient supplementation and food prices in HIV treatment.

Authors:  Kevin A Sztam; Wafaie W Fawzi; Christopher Duggan
Journal:  J Nutr       Date:  2009-11-25       Impact factor: 4.798

2.  HIV prevalence and impact on renutrition in children hospitalised for severe malnutrition in Niger: an argument for more systematic screening.

Authors:  Yoann Madec; David Germanaud; Violeta Moya-Alvarez; Wafa Alkassoum; Aichatou Issa; Morou Amadou; Stephanie Tchiombiano; Cecilia Pizzocolo; Florence Huber; Sanata Diallo; Roubanatou Abdoulaye-Mamadou
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

3.  The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme on Immunization schedule.

Authors:  Joanah Ikobah; Henry Okpara; Iwasam Elemi; Yeonun Ogarepe; Ekong Udoh; Emmanuel Ekanem
Journal:  Pan Afr Med J       Date:  2016-03-25

Review 4.  The status of hepatitis B control in the African region.

Authors:  Lucy Breakwell; Carol Tevi-Benissan; Lana Childs; Richard Mihigo; Rania Tohme
Journal:  Pan Afr Med J       Date:  2017-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.